LAPADULA GIUSEPPE

Mezzadri, L., Soria, A., Ranzani, A., Malandrin, S., Sabbatini, F., Limonta, S., et al. (2025). Hepatitis B core antibody positivity is not associated with risk of transaminase elevation following switch to dual antiretroviral therapy. AIDS [10.1097/QAD.0000000000004227]. Detail

Kogan, M., Alviano, A., Catalano, M., Casiraghi, A., Ghilardi, G., Rindone, G., et al. (2025). Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient. AIDS RESEARCH AND THERAPY, 22(1) [10.1186/s12981-025-00717-9]. Detail

Luo, J., Pavlov, I., Tavernier, E., Perez, Y., Kharat, A., Mcnicholas, B., et al. (2025). Awake Prone Positioning in Adults With COVID-19: An Individual Participant Data Meta-Analysis. JAMA INTERNAL MEDICINE, 185(5), 572-581 [10.1001/jamainternmed.2025.0011]. Detail

Soria, A., Lapadula, G., Squillace, N., Colella, E., Sabbatini, F., Rugova, A., et al. (2025). Transaminase Decrease Upon Switch From TDF to TAF in PWH Is Modulated by HBV Status. In Special Issue: Abstracts From the 2025 Conference on Retroviruses and Opportunistic Infections (pp.185-185). Detail

Ripamonti, D., Comi, L., Francavilla, A., Valenti, D., Cossu, M., Moschese, D., et al. (2025). Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [10.1093/jac/dkaf119]. Detail